Mission-critical activities of HHS will continue during the Democrat-led government shutdown. Please use this site as a resource as the Trump Administration works to reopen the government for the American people.

Targeting Ebola Virus Replication through Pharmaceutical Intervention

Hansen, F. and Feldmann, H. (2021). Targeting Ebola Virus Replication through Pharmaceutical Intervention. (Abstract only.) Expert Opinion on Investigational Drugs. 30(3):201-226.
This article discusses pharmaceutical interventions which can be used to treat Ebola virus disease. In particular, it examines the FDA-approved monoclonal antibody Inmazeb and the possibility of combining this with other pharmaceuticals which disrupt viral replication.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.